Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$291.2K
25K shares
What this filing means
HARMON CYRUS plans to sell 25K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $291.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/24/2026ACC: 0001959173-26-005357
DirectorOfficer· Chief Technology Officer
Since Nov 2020
25K
Shares to sell
$291.2K
Approx. market value
12.50K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders Shares
Compensation
3/20/2007
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/20/2007 | Founders Shares Compensation | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
12.50K
Market value
$144.7K
7/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.50K
Market value
$146.4K
7/24/2026
Total
Units
25K
Value
$291.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/23/2026 | 12.50K | $144.7K | — | Completed |
| Planned — Approximate Date | ||||
7/24/2026 | 12.50K | $146.4K | NASDAQ | Planned |
| Total | 25K | $291.2K | ||